Topics

Teva CEO sees 2020 improvement

07:50 EST 10 Nov 2019 | Globes

Kare Schultz has reiterated that 2019 is a 'trough year' for Teva and that there will be a marginal improvement in operating profit next year.

Original Article: Teva CEO sees 2020 improvement

NEXT ARTICLE

More From BioPortfolio on "Teva CEO sees 2020 improvement"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...